Age and treatment class modify inflammatory risk after disease-modifying therapy discontinuation in older people with MS.

Carvajal R, Marcialis C, Tur C, Otero-Romero S, Roos I, Pappolla A, Novak F, Cobo-Calvo A, Ariño H, Arrambide G, et al.

J Neurol Neurosurg Psychiatry. 2026 Sep 14. PMID: 42735930. Abstract